Adjuvant Chemotherapy Following Complete Resection of Soft Tissue Sarcoma in Adults
Version:
2
ID:
11-2
Oct 2014
Type of Content: Guidelines & Advice, Clinical
Document Status: Education and Information
Patient Population
Adult patients with resected soft tissue sarcoma.
Research Question(s)
- What are the benefits of anthracycline-based adjuvant chemotherapy in adult patients with completely resected soft tissue sarcomas, in terms of local disease control, systemic recurrence, and overall survival?
- When these benefits are assessed in the context of expected toxicities, in what circumstances should adjuvant chemotherapy be recommended?
- Are there any advantages in using combination versus single-agent anthracycline-based chemotherapy in the adjuvant setting?
